超声引导下经皮胆囊胆管造影联合微泡用于超声表现模棱两可且胆囊长度大于1.5 cm的婴儿胆道闭锁评估:一项初步研究
本初步研究纳入9例结合性高胆红素血症且超声胆囊长度大于1.5 cm的婴儿,在超声表现模棱两可或胆道闭锁类型不明时行超声引导下经皮胆囊胆管造影。操作全部成功且无并发症,4例诊断胆道闭锁、5例排除,作者认为该技术可能安全有效地早期排除胆道闭锁。
要点
- 超声胆囊长度大于1.5 cm但表现模棱两可时,可用超声引导下经皮胆囊胆管造影早期排除胆道闭锁。
- 造影剂显示胆囊、肝总管、胆总管并进入十二指肠即可排除胆道闭锁。
- 超声诊断胆道闭锁的征象为纤维索带征大于2 mm及胆囊长宽比大于5.2。
核心结论
- 在这组高度选择的胆道闭锁类型不明或超声表现不确定的婴儿中,超声引导下经皮胆囊胆管造影诊断胆道闭锁4例、排除5例。
- 超声引导下经皮胆囊胆管造影可能是一种安全有效的工具,用于超声表现模棱两可的婴儿早期排除胆道闭锁。
研究设计与样本
- 本研究为初步研究,2016年2月至2016年12月纳入9例结合性高胆红素血症且超声胆囊长度大于1.5 cm的婴儿(男4例、女5例;平均年龄60.2天,中位年龄57天,年龄范围23-117天)。
- 7例因超声表现模棱两可、2例因胆道闭锁类型不明而转诊行超声引导下经皮胆囊胆管造影。
- 操作使用配备对比脉冲序列、对比特异性软件及线阵探头的超声仪,经18G针注入稀释造影剂。
- 超声及超声引导下经皮胆囊胆管造影图像由两名放射科医师共识评估;造影后诊断为胆道闭锁者以手术或肝活检为参考标准。
关键影像表现/征象
- 超声诊断胆道闭锁的征象为纤维索带征(大于2 mm)和胆囊长宽比大于5.2。
- 超声引导下经皮胆囊胆管造影排除胆道闭锁的标准为造影剂显示于胆囊、肝总管、胆总管并进入十二指肠。
诊断标准与关键数值
- 超声诊断胆道闭锁标准:纤维索带征大于2 mm、胆囊长宽比大于5.2。
- 超声引导下经皮胆囊胆管造影排除胆道闭锁标准:造影剂显示于胆囊、肝总管、胆总管并进入十二指肠。
- 9例中超声引导下经皮胆囊胆管造影成功9例,无操作相关并发症;排除胆道闭锁5例,诊断胆道闭锁4例(手术证实2例、肝活检证实2例)。
- 排除胆道闭锁的5例中,血清直接胆红素中位数在造影后1周从91.1 μmol/L(四分位距81.6-113.8 μmol/L)降至65.3 μmol/L(四分位距57.8-74.7 μmol/L),差异无统计学意义(P = .062)。
- 2例胆道闭锁类型不明者中,1例定义为III型不伴胆总管通畅,另1例定义为III型伴胆总管通畅。
临床应用与阅片要点
- 对超声胆囊长度大于1.5 cm且胆道闭锁征象模棱两可的婴儿,可考虑行超声引导下经皮胆囊胆管造影以早期排除胆道闭锁。
- 阅片时注意测量纤维索带征厚度及胆囊长宽比,作为超声提示胆道闭锁的参考征象。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the feasibility of ultrasonographically (US) guided percutaneous cholecystocholangiography (PCC) for early exclusion of biliary atresia (BA) in infants suspected of having BA with equivocal US findings or indeterminate type of BA and a gallbladder longer than 1.5 cm at US. Materials and Methods This study was approved by the ethics committee; written informed parental consent was obtained. From February 2016 to December 2016, nine infants (four boys, five girls; mean age, 60.2 days; median age, 57 days; age range, 23-117 days) with conjugated hyperbilirubinemia and gallbladder longer than 1.5 cm at US were referred for US-guided PCC after US findings were equivocal for BA (n = 7) or the type of BA was unclear (n = 2). PCC was performed with a US machine with incorporated contrast pulse sequencing, contrast-specific software, and a linear transducer by injecting diluted contrast material via an 18-gauge needle. Images from US and US-guided PCC were evaluated in consensus by two radiologists. US criteria for BA were fibrotic cord sign (>2 mm) and gallbladder length-to-width ratio greater than 5.2. BA was excluded at PCC when contrast material was visualized in the gallbladder, common hepatic ducts, and common bile duct and during passage to the duodenum. Patients in whom BA was diagnosed after PCC underwent surgery or liver biopsy as the reference standard. Nonparametric and Fisher exact tests were used. Results US-guided PCC was successful in all patients. There were no procedural-related complications. BA was excluded in five of the nine patients. The median serum direct bilirubin level in these patients slightly decreased 1 week after PCC, from 91.1 μmol/L (interquartile range [IQR], 81.6-113.8 μmol/L) to 65.3 μmol/L (IQR, 57.8-74.7 μmol/L); however, this difference was not statistically significant (P = .062). BA was diagnosed in four patients, with the diagnosis confirmed at surgery (n = 2) or liver biopsy (n = 2). BA in two patients with unclear type of BA was defined as type III without patency of the common bile duct in one patient and as type III with patency of the common bile duct in the other. Conclusion In this highly selected group of infants with indeterminate type of BA or inconclusive US findings, US-guided PCC enabled the diagnosis of BA in four infants and the exclusion of BA in five. US-guided PCC may be a safe and effective tool to exclude BA early in infants with equivocal US findings. © RSNA, 2017.
引用
- Zhou LY, Chen SL, Chen HD, et al. Percutaneous US-guided Cholecystocholangiography with Microbubbles for Assessment of Infants with US Findings Equivocal for Biliary Atresia and Gallbladder Longer than 1.5 cm: A Pilot Study. Radiology. 2017. PMID: 28980885. doi:10.1148/radiol.2017170173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。